Showing results (271-280 of 293) with videos related to
Sort By:
Pageof 30
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2024
A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11Vered Stearns, Opeyemi A Jegede, Victor T-S Chang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 6, 2021
E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research GroupRoisin M Connolly, Fengmin Zhao, Kathy D Miller, et al.NPJ Breast Cancer|October 12, 2019
Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancerDavid B Page, Harry Bear, Sangeetha Prabhakaran, et al.NPJ Breast Cancer|January 6, 2026
Racial disparity in pro-metastatic tumor microenvironment in treatment naïve breast cancerPriyanka Parmar, Burcu Karadal-Ferrena, Suryansh Shukla, et al.Journal of the National Cancer Institute|May 3, 2018
Simulation Modeling of Cancer Clinical Trials: Application to Omitting Radiotherapy in Low-risk Breast CancerJinani Jayasekera, Yisheng Li, Clyde B Schechter, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2024
ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-Induced Peripheral Neuropathy in Black Women With Early-Stage Breast CancerBryan P Schneider, Fengmin Zhao, Tarah J Ballinger, et al.Radiology|August 3, 2021
Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial)Shinn-Huey S Chou, Justin Romanoff, Constance D Lehman, et al.NEJM Evidence|July 23, 2024
Clinical and Genomic Risk for Late Breast Cancer Recurrence and SurvivalJoseph A Sparano, Michael Crager, Robert J Gray, et al.Cancer Discovery|January 21, 2025
Bone-Induced HER2 Promotes Secondary Metastasis in HR+/HER2- Breast CancerRahat Alam, Anna Reva, David G Edwards, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 7, 2021
Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131Ingrid A Mayer, Fengmin Zhao, Carlos L Arteaga, et al.Pageof 30